Jinyao Biotechnology

Jinyao Biotechnology, a key subsidiary of the Tianjin Jinyao Group, is a leading Chinese pharmaceutical enterprise specializing in the research, development, and large-scale production of corticosteroid hormones and amino acid preparations. The company is globally recognized as one of the largest manufacturing bases for dexamethasone and other steroid APIs, maintaining a significant share of the international market. Its operations span the entire pharmaceutical value chain, including advanced fermentation, chemical synthesis, and the manufacturing of finished dosage forms such as tablets, injections, and ointments. Jinyao's products are widely used to treat inflammatory conditions, dermatological disorders, and respiratory diseases. The company leverages its integrated R&D capabilities to continuously expand its portfolio of high-quality steroid drugs and specialty biologics. With multiple international GMP certifications, Jinyao serves as a critical supplier to the global healthcare industry.